|
業務類別
|
-- |
|
業務概覽
|
3SBio Inc is an investment holding company. It is a primary biotechnology company. The company is principally engaged in the development, production, marketing and sale of biopharmaceutical products in the People's Republic of China. The group has only one operating segment. It has presence in Chinese mainland, USA, Other countries/regions. The majority of revenue comes from USA. The core commercialized products of the group include several bio-pharmaceutical drugs, namely, TPIAO, recombinant human erythropoietin (rhEPO) products EPIAO and SEPO, Yisaipu and Cipterbin, and a small molecule drug, Mandi series of minoxidil drugs. |
| 公司地址
| No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN |
| 電話號碼
| +86 2425386000 |
| 傳真號碼
| +86 2425811821 |
| 公司網頁
| https://www.3sbio.com |
| 員工數量
| 6109 |
| Ms. Dongmei Su |
Director and Senior Vice President |
-- |
29/04/2026 |
| Dr. Jing Lou, M.D.,PhD |
Chief Executive Officer, Chairman of the Board and President |
-- |
29/04/2026 |
|
|
| Ms. Dongmei Su |
Director and Senior Vice President |
29/04/2026 |
| Dr. Jing Lou, M.D.,PhD |
Chief Executive Officer, Chairman of the Board and President |
29/04/2026 |
| Mr. Tianruo Pu |
Independent Director |
29/04/2026 |
| Ms. Hoi Ti Heidi Yang |
Independent Director |
29/04/2026 |
| Mr. Joo Yeow Gerry NG |
Independent Director |
29/04/2026 |
| Ms. Jiaoe Zhang |
Director |
29/04/2026 |
|
|
|
|
